Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status

Conditions: Colorectal Cancer; Colorectal Neoplasms Interventions: Drug: Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens Sponsors: Sun Jing Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials